Endocrinology

The location of a broken bone can significantly impact the long-term health outcomes of older individuals, according to the new research findings to be presented at the Endocrine Society (ENDO) 2020 Annual Scientific Sessions.

An AI tool identified a near five-fold higher amount of potential fractures than the manual method.

An artificial intelligence tool trained to pinpoint patients with broken bones who are also at risk for osteoporosis outperforms radiologists who manually read the reports, a new study has found.

For every 1% higher baseline A1C, there was a 0.06 lower standardized CASI z-score.

A new subanalysis from the TWILIGHT trial found benefits of ticagrelor monotherapy remained consistent across both diabetics and nondiabetics.

Discussing the impact of rivaroxaban 2.5 mg BID plus aspirin in diabetics versus nondiabetics from the COMPASS trial with Deepak Bhatt, MD.

A board member of the college highlights 4 highly anticipated trials coming out of ACC 2020.

Screening for hypothyroidism should be considered for patients with alkaptonuria, according to recent study findings.

New research from a team of European investigators suggests age at the onset of puberty could serve as an independent risk factor for type 2 diabetes (T2D).

Patients treated at verified level I trauma centers are more likely to receive 5-6 evidence-based practices.

A study’s proposed findings of increased coronavirus risk shows how presenting half of a fact can influence our care during a pandemic.

Patients with alkaptonuria have a higher prevalence of primary hypothyroidism.

An ACC board member explains the major cardiology college's decision to move the meeting online during the COVID-19 pandemic.

The Mount Sinai expert and ACC late-breaking presentation panelist highlights her most anticipated trial data and discussions in the upcoming meeting.

A new study of more than 30k Swedish men is shedding light on associations between early puberty and risk of T2D.

Muthiah Vaduganathan, MD, MPH, discusses how research of the add-on drug class will continue to evolve into 2021.

What's known about at-risk cardiometabolic patient care during the pandemic.

A discussion with a Brigham and Women's Hospital cardiologist on the research of the add-on cardiometabolic drug class.

Technology, data, and community partnerships can help improve the overall health of patients with chronic health conditions.

Telehealth tools can identify someone whose symptoms are worsening and connect them to a medical professional.

Digital tools like electronic health records play an important role in addressing care for patients with chronic health conditions.

Roy Schoenberg, MD, MPH, discusses the populations that can most benefit from using telehealth tools and Medicare reimbursement obstacles.

Endometriosis risk indicators are apparent at early ages, which could speed up diagnosis and treatment of the condition.

A new study is diving into differences in long-term outcomes, including remission rates and weight loss, seen among patients undergoing RYGB and SG.

A 6-year-old girl was brought to her pediatrician for vaginal bleeding, breast enlargement, brown patches on her cheeks, back, and trunk. Can you diagnose this patient?

An analysis of 180,000 patients in South Korea is shedding new light on the potential poor oral hygiene can have on a person's risk of diabetes.

With approval, the GLP-1 receptor agonist becomes the first diabetes drug approved for reducing MACE in patients with and without established cardiovascular.

A look back on the biggest discussions of the 29th Annual Cardiovascular Conference in Beaver Creek, CO.

A new analysis is revealing more about how using a patient portal can aid in medication adherence and HbA1c management among diabetics.

Researchers writing in Diabetes Care this month report that empagliflozin, a sodium–glucose cotransporter 2 inhibitor (SGLT2), successfully reduced liver fat content in recent-onset and metabolically well-controlled type 2 diabetes (T2D).